References

The risk of Long Covid symptoms: a systematic review and meta-analysis of controlled studies

O’Mahoney, L. L., Routen, A., Gillies, C. et al.

Nature Communications (2025)

DOI: 10.1038/s41467-025-59012-w

Global prevalence of long COVID and its most common symptoms among healthcare workers: a systematic review and meta-analysis

Al-Oraibi, A., Woolf, K., Naidu, J. et al.

BMJ Public Health (2025)

DOI: 10.1136/bmjph-2023-000269

The public health and economic burden of long COVID in Australia, 2022–24: a modelling study

Costantino, V., Grafton, Q., Kompas, T. et al.

Medical Journal of Australia (2024)

DOI: 10.5694/mja2.52400

Admission screening testing of patients and staff N95 respirators are cost-effective in reducing COVID-19 hospital-acquired infections

McAndrew, F., Abeysuriya, R., Sacks-Davis, R. et al.

Journal of Hospital Infection (2024)

DOI: 10.1016/j.jhin.2024.06.015

Relative burden of healthcare associated COVID infections compared to other reportable healthcare associated infections (HAI) assuming ongoing continuous surveillance.

Canning, M. & Kainer, M. A.

Infection, Disease & Health (2024)

DOI: 10.1016/j.idh.2024.09.036

Perioperative and anesthetic considerations for post-acute sequelae of COVID (PASC)/long COVID

Yogendra, R., Perlowski, A., Johng, B. et al.

Perioperative Medicine (2025)

DOI: 10.1186/s13741-025-00558-0

Why scientists are rethinking the immune effects of SARS-CoV-2

Tsergas & Nick

BMJ (2025)

DOI: 10.1136/bmj.r1733

Tissue-based T cell activation and viral RNA persist for up to 2 years after SARS-CoV-2 infection

Peluso, M. J., Ryder, D., Flavell, R. R. et al.

Science Translational Medicine (2024)

DOI: 10.1126/scitranslmed.adk3295

SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC)

Proal, A. D., VanElzakker, M. B., Aleman, S. et al.

Nature Immunology (2023)

DOI: 10.1038/s41590-023-01601-2

Neuroimmune pathophysiology of long COVID

Moen, J. K., Baker, C. A., Iwasaki, A. et al.

Psychiatry and Clinical Neurosciences (2025)

DOI: 10.1111/pcn.13855

Autoantibodies in long COVID: a systematic review.

Wilhelm, F., Cadamuro, J., Mink, S.

Lancet Infectious Diseases (2025)

DOI: 10.1016/S1473-3099(25)00411-6

Association Between COVID-19 Infection and Thyroid Cancer Development: A Retrospective Cohort Study Using the TriNetX Database

Wang, H.-Y., Lin, Y.-C., Hou, J.-U. et al.

Biomedicines (2025)

DOI: 10.3390/biomedicines13081933

COVID-19, Flu May Reawaken Dormant Cancer Cells

Anderer & Samantha

JAMA (2025)

DOI: 10.1001/jama.2025.14772

Respiratory viral infections awaken metastatic breast cancer cells in lungs

Chia, S. B., Johnson, B. J., Hu, J. et al.

Nature (2025)

DOI: 10.1038/s41586-025-09332-0

SARS-CoV-2 infection heightens the risk of developing HPV-related carcinoma in situ and cancer

Shih, Y.-H., Yang, C.-Y., Lung, C.-C. et al.

Discover Oncology (2025)

DOI: 10.1007/s12672-025-03403-4

Comparing risk of post infection erectile dysfunction following SARS Coronavirus 2 stratified by acute and long COVID, hospitalization status, and vasopressor administration: a U.S. large claims database analysis

Grutman, A. J., Gilliam, K., Maremanda, A. P. et al.

International Journal of Impotence Research (2024)

DOI: 10.1038/s41443-024-00913-7

COVID-19 infection may reduce serum testosterone levels and increase the risk of erectile dysfunction: A two-sample Mendelian randomization study

Wang, T., Li, C., Song, J. et al.

Investigative and Clinical Urology (2025)

DOI: 10.4111/icu.20240384

COVID-19 infection was associated with poor sperm quality: a cross-sectional and longitudinal clinical observation study

Yuan, L., Sun, W., Dong, Z. et al.

Scientific Reports (2025)

DOI: 10.1038/s41598-025-94570-5

Dr Nancy Malek

STUDIES

COVID for Doctors: WEEK 1

LONG COVID